|Bid||5.75 x 3000|
|Ask||6.10 x 1200|
|Day's Range||5.71 - 6.29|
|52 Week Range||4.61 - 55.47|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jan 10, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||15.36|
SEATTLE, May 09, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will participate in the following upcoming investor conferences. A webcast and replay of each event will be available at ir.accolade.com. Thursday, May 12 at 1pm ET. BofA Securities 2022 Healthcare Conference at the Encore Hotel in Las VegasMonday, May 16 at 9:30am ET. 17th Annual Needham Technology & Media Conference (virtual) About Accolade, Inc. Accolade (Nasdaq: ACCD) provides millions of people a
With me on the call today are our chief executive officer, Rajeev Singh; and our chief financial officer, Steve Barnes. Shantanu Nundy, our chief medical officer, will join us for the question-and-answer portion of the call.
Accolade (ACCD) delivered earnings and revenue surprises of -17.39% and 1.82%, respectively, for the quarter ended February 2022. Do the numbers hold clues to what lies ahead for the stock?